Table 4.
Variable | Modela 1 OR (95% CI) | P Value | Modela 2 OR (95% CI) | P Value | Modela 3 OR (95% CI) | P Value | |
---|---|---|---|---|---|---|---|
Quartiles | Fibrocystic breast change | ||||||
Total lean mass | Q2 v.s. Q1 | 0.857 (0.634, 1.158) | 0.315 | 0.840 (0.613, 1.150) | 0.276 | 0.845 (0.617, 1.158) | 0.294 |
Q3 v.s. Q1 | 1.002 (0.749, 1.341) | 0.988 | 1.081 (0.782, 1.493) | 0.638 | 1.112 (0.803, 1.539) | 0.522 | |
Q4 v.s. Q1 | 0.084 (0.058, 0.122) | <0.001 | 0.235 (0.146, 0.379) | <0.001 | 0.279 (0.171, 0.455) | <0.001 | |
PBF | Q2 v.s. Q1 | 2.167 (1.512, 3.104) | <0.001 | 1.494 (1.021, 2.188) | 0.039 | 1.378 (0.939, 2.023) | 0.101 |
Q3 v.s. Q1 | 3.320 (2.336, 4.718) | <0.001 | 1.864 (1.248, 2.786) | 0.002 | 1.610 (1.071, 2.420) | 0.022 | |
Q4 v.s. Q1 | 4.794 (3.407, 6.748) | <0.001 | 2.935 (1.843, 4.673) | <0.001 | 2.451 (1.523, 3.944) | <0.001 |
aAdjusted covariates:
Model 1 = unadjusted.
Model 2 = Model 1 + age + BMI + proteinuria, serum total cholesterol, uric acid, creatinine, AST, albumin, hsCRP, TSH.
Model 3 = Model 2 + history of smoking, drinking.
Range of TLM in quartile.
Q1: <19.20; Q2: 19.20–21.20; Q3: 21.20–23.80; Q4: >23.80.
Range of PBF in quartile.
Q1: <25.90; Q2: 25.90–30.90; Q3: 30.90–35.60; Q4: >35.60.